Fig. 3From: Anastrozole for the prevention of breast cancer in high-risk postmenopausal women: cost-effectiveness analysis in the UK and the USACost-Effectiveness scattar plot of probabilistic sensitivity analysis for anastrozole prevention versus placebo. A UK of 5-year time horizon model; B UK of 12-year time horizon model; C USA of 5-year time horizon model; D USA of 12-year time horizon model)Back to article page